Cost Recovery Implementation Statement 2025–2026

This document describes the processes to determine fees for applications to provide medicines subsidised by the Pharmaceutical Benefits Scheme. It also outlines the current and forecasted financial performance of the process.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.